Artificial Intelligence-Assisted Interpretation of Ophthalmic Images for Early Detection of Retinal Diseases

References

[1] Olawade, D.B.; Weerasinghe, K.; Mathugamage, M.D.D.E.; Odetayo, A.; Aderinto, N.; Teke, J.; Boussios, S. Enhancing Ophthalmic Diagnosis and Treatment with Artificial Intelligence. Medicina 2025, 61(3), 433. https://doi.org/10.3390/medicina61030433.

[2] Tan, T.F.; Thirunavukarasu, A.J.; Jin, L.; et al. Artificial Intelligence and Digital Health in Global Eye Health: Opportunities and Challenges. The Lancet Global Health 2023, 11(9), e1432-e1443. https://doi.org/10.1016/S2214-109X(23)00323-6.

[3] Kropp, M.; Golubnitschaja, O.; Mazurakova, A.; et al. Diabetic Retinopathy as the Leading Cause of Blindness and Early Predictor of Cascading Complications-Risks and Mitigation. EPMA Journal 2023, 14(1), 21-42. https://doi.org/10.1007/s13167-023-00314-8.

[4] Wolf, R.M.; Channa, R.; Liu, T.Y.A.; et al. Autonomous Artificial Intelligence Increases Screening and Follow-Up for Diabetic Retinopathy in Youth: The ACCESS Randomized Controlled Trial. Nature Communications 2024, 15, 421. https://doi.org/10.1038/s41467-023-44676-z.

[5] Campbell, J.P.; Mathenge, C.; Cherwek, H.; Balaskas, K.; Pasquale, L.R.; Keane, P.A.; Chiang, M.F. Artificial Intelligence to Reduce Ocular Health Disparities: Moving from Concept to Implementation. Translational Vision Science & Technology 2021, 10(3), 19. https://doi.org/10.1167/tvst.10.3.19.

[6] Joseph, S.; Selvaraj, J.; Mani, I.; Kumaragurupari, T.; Shang, X.; Mudgil, P.; Ravilla, T.; He, M. Diagnostic Accuracy of Artificial Intelligence-Based Automated Diabetic Retinopathy Screening in Real-World Settings: A Systematic Review and Meta-Analysis. American Journal of Ophthalmology 2024, 263, 214-230. https://doi.org/10.1016/j.ajo.2024.02.012.

[7] Chokshi, T.; Cruz, M.J.; Ross, J.; Yiu, G. Advances in Teleophthalmology and Artificial Intelligence for Diabetic Retinopathy Screening: A Narrative Review. Annals of Eye Science 2024, 9, 9. https://doi.org/10.21037/aes-23-10.

[8] Pieczynski, J.; Kuklo, P.; Grzybowski, A. The Role of Telemedicine, In-Home Testing and Artificial Intelligence to Alleviate an Increasingly Burdened Healthcare System: Diabetic Retinopathy. Ophthalmology and Therapy 2021, 10, 445-464. https://doi.org/10.1007/s40123-021-00353-2.

[9] Mursch-Edlmayr, A.S.; Ng, W.S.; Diniz-Filho, A.; Sousa, D.C.; Arnould, L.; et al. Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice. Translational Vision Science & Technology 2020, 9(2), 55. https://doi.org/10.1167/tvst.9.2.55.

[10] Zhu, Y.; Salowe, R.; Chow, C.; et al. Advancing Glaucoma Care: Integrating Artificial Intelligence in Diagnosis, Management, and Progression Detection. Bioengineering 2024, 11(2), 122. https://doi.org/10.3390/bioengineering11020122.

[11] Yousefi, S. Clinical Applications of Artificial Intelligence in Glaucoma. Journal of Ophthalmic & Vision Research 2023, 18(1), 97-112. https://doi.org/10.18502/jovr.v18i1.12730.

[12] Zhang, L.; Tang, L.; Xia, M.; Cao, G. The Application of Artificial Intelligence in Glaucoma Diagnosis and Prediction. Frontiers in Cell and Developmental Biology 2023, 11, 1173094. https://doi.org/10.3389/fcell.2023.1173094.

[13] Hussain, S.; Chua, J.; Wong, D.; et al. Predicting Glaucoma Progression Using a Deep Learning Framework Guided by a Generative Algorithm. Scientific Reports 2023, 13, 19960. https://doi.org/10.1038/s41598-023-46253-2.

[14] Bhartiya, S. Glaucoma Screening: Is AI the Answer? Journal of Current Glaucoma Practice 2022, 16(2), 71-73. https://doi.org/10.5005/jp-journals-10078-1380.

[15] Fleckenstein, M.; Schmitz-Valckenberg, S.; Chakravarthy, U. Age-Related Macular Degeneration: A Review. JAMA 2024, 331(2), 147-157. https://doi.org/10.1001/jama.2023.26074.

[16] Elsharkawy, M.; Elrazzaz, M.; Ghazal, M.; et al. Role of Optical Coherence Tomography Imaging in Predicting Progression of Age-Related Macular Disease: A Survey. Diagnostics 2021, 11(12), 2313. https://doi.org/10.3390/diagnostics11122313.

[17] Muntean, G.A.; Marginean, A.; Groza, A.; et al. The Predictive Capabilities of Artificial Intelligence-Based OCT Analysis for Age-Related Macular Degeneration Progression: A Systematic Review. Diagnostics 2023, 13(14), 2464. https://doi.org/10.3390/diagnostics13142464.

[18] Thakoor, K.A.; Yao, J.; Bordbar, D.; et al. A Multimodal Deep Learning System to Distinguish Late Stages of AMD and to Compare Expert versus AI Ocular Biomarkers. Scientific Reports 2022, 12, 2585. https://doi.org/10.1038/s41598-022-06273-w.

[19] Mares, V.; Nehemy, M.B.; Bogunovic, H.; et al. AI-Based Support for Optical Coherence Tomography in Age-Related Macular Degeneration. International Journal of Retina and Vitreous 2024, 10, 31. https://doi.org/10.1186/s40942-024-00549-1.

[20] Saleh, G.A.; Batouty, N.M.; Haggag, S.; et al. The Role of Medical Image Modalities and AI in the Early Detection, Diagnosis and Grading of Retinal Diseases: A Survey. Bioengineering 2022, 9(8), 366. https://doi.org/10.3390/bioengineering9080366.

[21] Liu, X.; Zhao, C.; Wang, L.; Wang, G.; Lv, B.; Lv, C.; Xie, J.; Wang, N. Evaluation of an OCT-AI-Based Telemedicine Platform for Retinal Disease Screening and Referral in a Primary Care Setting. Translational Vision Science & Technology 2022, 11(3), 4. https://doi.org/10.1167/tvst.11.3.4.

[22] Mantena, S.; Celi, L.A.; Keshavjee, S.; Beratarrechea, A. Improving Community Health-Care Screenings with Smartphone-Based AI Technologies. The Lancet Digital Health 2021, 3(5), e280-e282. https://doi.org/10.1016/S2589-7500(21)00054-6.

[23] Parmar, U.P.S.; Surico, P.L.; Singh, R.B.; et al. Artificial Intelligence for Early Diagnosis of Retinal Diseases. Medicina 2024, 60(4), 527. https://doi.org/10.3390/medicina60040527.

[24] Chen, T.C.; Lim, W.S.; Wang, V.Y.; et al. Artificial Intelligence-Assisted Early Detection of Retinitis Pigmentosa-The Most Common Inherited Retinal Degeneration. Journal of Digital Imaging 2021, 34(4), 948-958. https://doi.org/10.1007/s10278-021-00479-6.

[25] Ji, Y.K.; Hua, R.R.; Liu, S.; et al. Intelligent Diagnosis of Retinal Vein Occlusion Based on Color Fundus Photographs. International Journal of Ophthalmology 2024, 17(1), 1-6. https://doi.org/10.18240/ijo.2024.01.01.

[26] Huang, S.; Jin, K.; Gao, Z.; et al. Automated Interpretation of Retinal Vein Occlusion Based on Fundus Fluorescein Angiography Images Using Deep Learning: A Retrospective, Multicenter Study. Heliyon 2024, 10(13), e33108. https://doi.org/10.1016/j.heliyon.2024.e33108.

[27] Li, Z.; Wang, L.; Wu, X.; et al. Artificial Intelligence in Ophthalmology: The Path to the Real-World Clinic. Cell Reports Medicine 2023, 4(7), 101095. https://doi.org/10.1016/j.xcrm.2023.101095.

[28] Jin, K.; Li, Y.; Wu, H.; et al. Integration of Smartphone Technology and Artificial Intelligence for Advanced Ophthalmic Care: A Systematic Review. Advances in Ophthalmology Practice and Research 2024, 4(3), 120-127. https://doi.org/10.1016/j.aopr.2024.03.003.

[29] Evans, N.G.; Wenner, D.M.; Cohen, I.G.; et al. Emerging Ethical Considerations for the Use of Artificial Intelligence in Ophthalmology. Ophthalmology Science 2022, 2(2), 100141. https://doi.org/10.1016/j.xops.2022.100141.

[30] Tom, E.; Keane, P.A.; Blazes, M.; Pasquale, L.R.; Chiang, M.F.; Lee, A.Y.; Lee, C.S. Protecting Data Privacy in the Age of AI-Enabled Ophthalmology. Translational Vision Science & Technology 2020, 9(2), 36. https://doi.org/10.1167/tvst.9.2.36.

@article{1722392,
      author = {Muhammad Qasim},
      title = {Artificial Intelligence-Assisted Interpretation of Ophthalmic Images for Early Detection of Retinal Diseases},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {10},
      number = {2},
      pages = {2299-2311},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1722392.pdf},
      abstract = {Retinal diseases constitute major causes of avoidable visual impairment, with early manifestations that are frequently subtle, spatially distributed, and challenging to interpret consistently, particularly in busy or under-resourced clinical settings. Artificial intelligence-assisted interpretation of ophthalmic images enables earlier recognition by transforming fundus photographs, optical coherence tomography, optical coherence tomography angiography, and multimodal records into reproducible estimates of disease presence, severity, and referral urgency. This review thoroughly examines evidence published from 2020 to 2025 regarding image-based artificial intelligence for early detection of diabetic retinopathy, age-related macular degeneration, glaucoma, retinal vascular occlusion, and inherited retinal degeneration. In contrast to broad reviews of artificial intelligence in ophthalmology, this work focuses on the entire early-detection pathway, including image acquisition, quality control, lesion localization, diagnostic classification, uncertainty communication, clinical triage, and longitudinal monitoring. A structured narrative review was carried out using PubMed, Scopus, Web of Science, IEEE Xplore, and ScienceDirect, employing targeted searches that combined retinal disease terms, imaging modalities, artificial intelligence methods, screening, validation, explainability, and clinical deployment. Evidence was synthesized with respect to diagnostic performance, transportability, workflow value, and patient-safety requirements. While deep learning systems are able to achieve high discrimination in selected datasets, their real-world value depends on image quality, spectrum diversity, external validation, calibration, interoperable reporting, and clinically meaningful thresholds. Fundus photography remains highly scalable for population screening, whereas optical coherence tomography and multimodal models provide more comprehensive structural and temporal information for macular and glaucomatous disease. The review concludes that artificial intelligence should serve as a supervised interpretation layer rather than an autonomous replacement for clinical judgment. Upcoming studies must prioritize prospective multicenter evaluation, subgroup fairness, uncertainty-aware outputs, privacy-preserving learning, and outcome-based comparisons that assess earlier treatment, preserved vision, and reduced inequity rather than accuracy alone.},
      keywords = {artificial intelligence; retinal imaging; early detection; fundus photography; optical coherence tomography; diabetic retinopathy; age-related macular degeneration; glaucoma; explainable AI},
      month = {August},
      doi = {https://doi.org/10.64388/IREV10I2-1722392}
  }